Navigation Links
Having OCP’s All Year Round to Eliminate Menstrual Cycles Not Unsafe: Says Stud

Researchers have shown that oral contraceptives taken on a long term basis to do away with menstrual cycle is safe to use.They claim that it is both safe and effective.The study// was published in the journal” Contraception”. There are low dose OCP’s in the market that help to reduce the number of menstrual periods to four in a year. This study is the first one to contend that it is safe to do away with menstrual periods altogether.

"It is felt that the relief of menstrual cycle symptoms during continuous use of the contraceptive is a significant improvement in the quality of life," said Archer.

Traditional birth-control regimens include 21 days of active hormones with seven days of placebos to continue monthly menstruation. During menstruation, many women suffer a variety of symptoms including headaches, bloating and irritability, Archer said.

In the study, conducted at 92 sites in North America, researchers used a birth-control pill consisting of 20 micrograms of ethinyl estradiol and 90 micrograms of levonorgestrel, a formulation marketed by Wyeth Pharmaceuticals under the name Lybrel. Healthy, sexually active women between 18 and 49 years old were given a continuous regimen without any breaks or placebos. During the course of the study, which lasted more than 18 months, the median and mean number of bleeding days decreased progressively. For the 2134 subjects enrolled, 79 percent reported an absence of bleeding after one year while 58.7 percent reported cessation of menstrual cycles. The study results demonstrated that the continuous-use, low-dose regimen was safe and as effective as traditional oral contraceptives.

Source-Eurekalert
MT
'"/>




Page: 1

Related medicine news :

1. Suicide Prevention Program – Having its Intended Effec
2. Common Infections Found To Raise An Individuals Risk Of Having A Heart Attack Or Stroke
3. Airlines Pilot At Heightened Risk Of Having Cataracts
4. Stressful Work Can Put Men At Risk Of Having Blocked Arteries
5. Complication More in Women Having IVF Treatment
6. Parental Supervision Reduces Likelihood of Teenagers Having Sex in the Afternoon
7. Murdered Nurse Was Having IVF Treatment
8. Hip Fracture Risk Increases In Men Having Low Estrogen Levels
9. Children Having An Early Exposure To Cats May Develop Eczema
10. Sex Workers Rewarded for Having HIV Check
11. North East Having Highest Cancer Incidences In Country
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will ... set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is ... of Medicine. He also serves as Medical Director for the Bureau of Emergency Medical ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
Breaking Medicine Technology: